VENFUZO
Dead / Abandoned — Abandoned — no statement of use filed (as of 11 Aug 2025)
What this means for you
This application is over — abandoned 11 Aug 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98113165
- Mark type
- Stylized text
- Filed
- 02 Aug 2023
- Published for opposition
- 14 May 2024
- Abandoned
- 11 Aug 2025
- Attorney of record
- Deborah L. Corpus
Goods and services
- Class 005 — Pharmaceuticals: Anti-infective, injectable pharmaceutical products in liquid finished dosage form for use in hospitals and clinics or by home health care professionals
Owner
- HIKMA PHARMACEUTICALS USA INC., BERKELEY HEIGHTS, NJ, US
- Xellia Pharmaceuticals ApS, Copenhagen S, DK
- Xellia Pharmaceuticals ApS, Copenhagen S, DK
Prosecution history
- 11 Aug 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Aug 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 02 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 May 2025 — SOU EXTENSION 1 GRANTED
- 08 Jan 2025 — SOU EXTENSION 1 FILED
- 14 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Feb 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 08 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Nov 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Nov 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Nov 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 May 2024 — PUBLISHED FOR OPPOSITION
- 24 Apr 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED